AAAAAA

   
Results: 1-16 |
Results: 16
15 YEAR UPDATE OF THE NAPLES GUN TRIAL OF ADJUVANT BREAST-CANCER THERAPY - EVIDENCE OF INTERACTION BETWEEN C-ERB-B2 EXPRESSION AND TAMOXIFEN EFFICACY
Authors: BIANCO AR DELAURENTIIS M CARLOMAGNO C LAURIA R PETRELLA G PANICO L PETTINATO G PERRONE F GALLO C MARINELLI A DEPLACIDO S
Citation: Ar. Bianco et al., 15 YEAR UPDATE OF THE NAPLES GUN TRIAL OF ADJUVANT BREAST-CANCER THERAPY - EVIDENCE OF INTERACTION BETWEEN C-ERB-B2 EXPRESSION AND TAMOXIFEN EFFICACY, European journal of cancer, 34, 1998, pp. 46-46
PHASE-I STUDY OF CARBOPLATIN, CISPLATIN, AND CYCLOPHOSPHAMIDE WITHOUTAND WITH LENOGRASTIM FOR THE TREATMENT OF OVARIAN-CANCER
Authors: PIGNATA S LAURIA R PERRONE F FERRARI E BIONDI E MAFFEO A MORABITO A GRAZIANO R CARLOMAGNO C DEPLACIDO G GALLO C BIANCO AR PERGOLA M DEPLACIDO S
Citation: S. Pignata et al., PHASE-I STUDY OF CARBOPLATIN, CISPLATIN, AND CYCLOPHOSPHAMIDE WITHOUTAND WITH LENOGRASTIM FOR THE TREATMENT OF OVARIAN-CANCER, International journal of oncology, 11(1), 1997, pp. 175-180
SELECTING HIGH-RISK EARLY BREAST-CANCER PATIENTS - WHAT TO ADD TO THENUMBER OF METASTATIC NODES
Authors: PERRONE F CARLOMAGNO C LAURIA R DELAURENTIIS M MORABITO A PANICO L PETTINATO G PETRELLA G GALLO C BIANCO AR DEPLACIDO S
Citation: F. Perrone et al., SELECTING HIGH-RISK EARLY BREAST-CANCER PATIENTS - WHAT TO ADD TO THENUMBER OF METASTATIC NODES, European journal of cancer, 32A(1), 1996, pp. 41-46
C-ERBB2 OVEREXPRESSION DECREASES THE BENEFIT OF ADJUVANT TAMOXIFEN INEARLY-STAGE BREAST-CANCER WITHOUT AXILLARY LYMPH-NODE METASTASES
Authors: CARLOMAGNO C PERRONE F GALLO C DELAURENTIIS M LAURIA R MORABITO A PETTINATO G PANICO L DANTONIO A BIANCO AR DEPLACIDO S
Citation: C. Carlomagno et al., C-ERBB2 OVEREXPRESSION DECREASES THE BENEFIT OF ADJUVANT TAMOXIFEN INEARLY-STAGE BREAST-CANCER WITHOUT AXILLARY LYMPH-NODE METASTASES, Journal of clinical oncology, 14(10), 1996, pp. 2702-2708
A PREDICTIVE INDEX OF AXILLARY NODAL INVOLVEMENT IN OPERABLE BREAST-CANCER
Authors: DELAURENTIIS M GALLO C DEPLACIDO S PERRONE F PETTINATO G PETRELLA G CARLOMAGNO C PANICO L DELRIO P BIANCO AR
Citation: M. Delaurentiis et al., A PREDICTIVE INDEX OF AXILLARY NODAL INVOLVEMENT IN OPERABLE BREAST-CANCER, British Journal of Cancer, 73(10), 1996, pp. 1241-1247
DNA-FLOW CYTOMETRY (PLOIDY AND S-PHASE FRACTION) AS PROGNOSTIC FACTORIN A RETROSPECTIVE SERIES OF 515 PRIMARY BREAST-CANCER
Authors: PEPE S RUGGIERO A DELAURENTIIS M NORMANNO N FIORENTINO B PERRONE F CARLOMAGNO C DEPLACIDO S PANICO L PETTINATO G BORRIELLO G BIANCO AR
Citation: S. Pepe et al., DNA-FLOW CYTOMETRY (PLOIDY AND S-PHASE FRACTION) AS PROGNOSTIC FACTORIN A RETROSPECTIVE SERIES OF 515 PRIMARY BREAST-CANCER, Oncology Reports, 2(3), 1995, pp. 345-350
ADJUVANT CHEMOENDOCRINE THERAPY FOR EARLY BREAST-CANCER - IS IT WORTHWHILE - (REVIEW)
Authors: PERRONE F DEPLACIDO S GALLO C CARLOMAGNO C LAURIA R BIANCO AR
Citation: F. Perrone et al., ADJUVANT CHEMOENDOCRINE THERAPY FOR EARLY BREAST-CANCER - IS IT WORTHWHILE - (REVIEW), International journal of oncology, 7(5), 1995, pp. 1129-1137
ERBB2 OVEREXPRESSION AFFECTS TAMOXIFEN EFFICACY IN THE ADJUVANT TREATMENT OF NODE-NEGATIVE OPERABLE BREAST-CANCER PATIENTS
Authors: CARLOMAGNO C PERRONE F LAURIA R DELAURENTIIS M GALLO C MORABITO A PETTINATO G PANICO L DEPLACIDO S BIANCO AR
Citation: C. Carlomagno et al., ERBB2 OVEREXPRESSION AFFECTS TAMOXIFEN EFFICACY IN THE ADJUVANT TREATMENT OF NODE-NEGATIVE OPERABLE BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 45-45
FIRST-LINE SYSTEMIC THERAPY FOR METASTATIC BREAST-CANCER AND MANAGEMENT OF PLEURAL EFFUSION
Authors: PERRONE F CARLOMAGNO C DEPLACIDO S LAURIA R MORABITO A BIANCO AR
Citation: F. Perrone et al., FIRST-LINE SYSTEMIC THERAPY FOR METASTATIC BREAST-CANCER AND MANAGEMENT OF PLEURAL EFFUSION, Annals of oncology, 6(10), 1995, pp. 1033-1043
THE FIRST BREAST-CANCER SCREENING-PROGRAM IN SOUTHERN ITALY - PRELIMINARY-RESULTS FROM 3 MUNICIPALITIES OF THE NAPLES PROVINCE
Authors: DEPLACIDO S NUZZO F PERRONE F CARLOMAGNO C NOVIELLO A DELRIO P DIPALMA E PINI MT CERATO PL BIANCO C RIVELLINI M PETRELLA G GALLO C SODANO A BIANCO AR
Citation: S. Deplacido et al., THE FIRST BREAST-CANCER SCREENING-PROGRAM IN SOUTHERN ITALY - PRELIMINARY-RESULTS FROM 3 MUNICIPALITIES OF THE NAPLES PROVINCE, Tumori, 81(1), 1995, pp. 7-12
PROGNOSTIC-SIGNIFICANCE OF NECROSIS, ELASTOSIS, FIBROSIS AND INFLAMMATORY CELL REACTION IN OPERABLE BREAST-CANCER
Authors: CARLOMAGNO C PERRONE F LAURIA R DELAURENTIIS M GALLO C MORABITO A PETTINATO G PANICO L BELLELLI T APICELLA A PETRELLA G BIANCO AR DEPLACIDO S
Citation: C. Carlomagno et al., PROGNOSTIC-SIGNIFICANCE OF NECROSIS, ELASTOSIS, FIBROSIS AND INFLAMMATORY CELL REACTION IN OPERABLE BREAST-CANCER, Oncology, 52(4), 1995, pp. 272-277
THE PROGNOSTIC VALUE OF LYMPHATIC AND BLOOD-VESSEL INVASION IN OPERABLE BREAST-CANCER
Authors: LAURIA R PERRONE F CARLOMAGNO C DELAURENTIIS M MORABITO A GALLO C VARRIALE E PETTINATO G PANICO L PETRELLA G BIANCO AR DEPLACIDO S
Citation: R. Lauria et al., THE PROGNOSTIC VALUE OF LYMPHATIC AND BLOOD-VESSEL INVASION IN OPERABLE BREAST-CANCER, Cancer, 76(10), 1995, pp. 1772-1778
CMF VS ALTERNATING CMF EV IN THE ADJUVANT TREATMENT OF OPERABLE BREAST-CANCER - A SINGLE-CENTER RANDOMIZED CLINICAL-TRIAL (NAPLES GUN-3 STUDY)/
Authors: DEPLACIDO S PERRONE F CARLOMAGNO C MORABITO A PAGLIARULO C LAURIA R MARINELLI A DELAURENTIIS M VARRIALE E PETRELLA G GALLO C BIANCO AR
Citation: S. Deplacido et al., CMF VS ALTERNATING CMF EV IN THE ADJUVANT TREATMENT OF OPERABLE BREAST-CANCER - A SINGLE-CENTER RANDOMIZED CLINICAL-TRIAL (NAPLES GUN-3 STUDY)/, British Journal of Cancer, 71(6), 1995, pp. 1283-1287
PROGNOSTIC-SIGNIFICANCE OF MULTIFOCALITY IN PRIMARY BREAST-CANCER
Authors: MORABITO A PERRONE F LAURIA R CARLOMAGNO C MARINELLI A DELAURENTIIS M MARTIGNETTI A PETTINATO G PANICO L PETRELLA G GALLO C BIANCO AR DEPLACIDO S
Citation: A. Morabito et al., PROGNOSTIC-SIGNIFICANCE OF MULTIFOCALITY IN PRIMARY BREAST-CANCER, Oncology Reports, 1(6), 1994, pp. 1045-1048
MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY
Authors: PERRONE F DEPLACIDO S CARLOMAGNO C GRAVINA A DELAURENTIIS M DELMASTRO L GRIDELLI C PAGLIARULO C BIANCO AR
Citation: F. Perrone et al., MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY, American journal of clinical oncology, 17(3), 1994, pp. 218-222
CHEMOTHERAPY WITH MITOMYCIN-C AND VINBLASTINE IN PRETREATED METASTATIC BREAST-CANCER
Authors: PERRONE F DEPLACIDO S CARLOMAGNO C NUZZO F RUGGIERO A DELAURENTIIS M GRIDELLI C PAGLIARULO C BIANCO AR
Citation: F. Perrone et al., CHEMOTHERAPY WITH MITOMYCIN-C AND VINBLASTINE IN PRETREATED METASTATIC BREAST-CANCER, Tumori, 79(4), 1993, pp. 254-257
Risultati: 1-16 |